-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Sanjay Saint, MD, MPH

Articles by Sanjay Saint, MD, MPH

Applying Organizational Behavior Theory to Primary Care

BySamyukta Mullangi, MD, MBA,Sanjay Saint, MD, MPH

March 14th 2017

Primary care physician recruitment and retention must rely on not only increased financial remuneration, but also on a redesign of workflow and processes.

Univariate Solutions in a Multivariate World: Can We Afford to Practice as in the "good old days"?

ByLaurence F. McMahon Jr, MD, MPH,Rodney Hayward, MD,Sanjay Saint, MD, MPH,Michael E. Chernew, PhD,A. Mark Fendrick, MD

August 1st 2005

Use of Critical Pathways to Improve Efficiency: A Cautionary Tale

BySanjay Saint, MD, MPH,Timothy P. Hofer, MD, MSc,Judith S. Rose, MS,Samuel R. Kaufman, MA,Laurence F. McMahon Jr, MD, MPH

November 1st 2003

Coronary Artery Bypass Grafting in Octogenarians: Clinical and Economic Outcomes at Community-Based Healthcare Facilities

ByBrahmajee K. Nallamothu, MD, MPH,Sanjay Saint, MD, MPH,Kim A. Eagle, MD,Kenneth M. Langa, MD, PhD,A. Mark Fendrick, MD,Robert V. Hogikyan, MD,

August 1st 2002

Latest Updated Articles

Use of Critical Pathways to Improve Efficiency: A Cautionary Tale
November 1st 2003
Applying Organizational Behavior Theory to Primary Care
March 14th 2017
Univariate Solutions in a Multivariate World: Can We Afford to Practice as in the "good old days"?
August 1st 2005
Coronary Artery Bypass Grafting in Octogenarians: Clinical and Economic Outcomes at Community-Based Healthcare Facilities
August 1st 2002

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS